Chemical formula: C₁₇H₂₇NO₂ Molecular mass: 277.402 g/mol PubChem compound: 5656
Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N06AX16 | Venlafaxine | N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| EFFEXOR XR Extended-release capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| DEPEFEX Prolonged-release capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Venlafaxine is an active ingredient of these brands:
United States (US)
Austria (AT)Brazil (BR)
Canada (CA)
Cyprus (CY)Ecuador (EC)
Estonia (EE)
Finland (FI)
France (FR)
Germany (DE)
Hong Kong (HK)
Ireland (IE)Italy (IT)Japan (JP)
Lithuania (LT)Malta (MT)Mexico (MX)
Netherlands (NL)
Poland (PL)
Romania (RO)Singapore (SG)South Africa (ZA)Spain (ES)
Tunisia (TN)Turkey (TR)United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
